As such, the true clinical relevance of this novel, insulin-independent pathway to improve whole-body glucose homeostasis (namely, three conditions: glucose tolerance, insulin resistance and hepatic steatosis) could be readily tested in humans. The gene discussed is INS; the disease is Insulin resistance.